(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TREEFROG THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TREEFROG THERAPEUTICS

ST13

US500000079273327

Class

1, 5, 9, 10, 42

Filing

79273327

Registration

6213500

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

12/09/2025

Trademark type

Combined

Nice classes

1, 5, 9, 10, 42

Filing date

10/10/2019

Registration date

12/08/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/08/2020

Last transaction

12/09/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

34

Owner location

FR

Examiner

HUSSAIN,TASNEEM

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "TREEFROG" in light green above the wording "THERAPEUTICS" in dark green. The "O" in "TREEFROG" is joined with the letter "G" and features a cut out in the shape of a frog's flipper. The color white represents background and is not part of the mark.

Holders and representatives

Holders

T. T. (pessoa física)

Representatives

Todd A. Denys Porzio, Bromberg & Newman, P.C.

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Stem cells for research; stem cells for scientific purposes; nutrition agentscell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical purposes

Class 5

Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseasesheart failurediabetesNon-Alcoholic Steatohepatitis and acute liver failureAge-related macular degeneration and limbal stem cells deficienciestraumatic injury and skin burns; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseasesheart failurediabetesNon-Alcoholic Steatohepatitis and acute liver failureAge-related macular degeneration and limbal stem cells deficienciestraumatic injury and skin burns; stem cells for medical or veterinary use; pluripotent stem cells for medical purposes intended for cell and gene therapies; cell culture media for cultivating human cells for medical or veterinary use; surgical implants comprised of living tissues obtained from stem cells

Class 9

Scientific apparatuscytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; scientific apparatuslaboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatusmicroscopes for cell culture; incubators for cell culture; cell culture apparatus for laboratory usecell culture dishes and tissue culture flaks; downloadable software used for the collectionanalysissortingcommunication of biological information relating to stem cells

Class 10

Apparatus for the regeneration of stem cells for medical use; apparatus for cell culture systems for medical purposescell culture chambers and capsules; apparatus for cell culture systems by encapsulation for medical purposescell culture chambers and capsules; apparatus for analyzing and sorting cell culture for medical purposescell culture chambers and capsules

Class 42

Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cellscell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing informations with respect to scientific research in the field of stem cellscell and gene therapy and biotechnology

Publications

History of USPTO decisions and trademark events.

33 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/08/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/24/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/04/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/16/2021

FIMP

FINAL DISPOSITION PROCESSED

03/15/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/08/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

12/08/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/22/2020

PUBO

PUBLISHED FOR OPPOSITION

09/22/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/17/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

08/06/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/06/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

08/06/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/06/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/30/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/29/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/29/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/28/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/28/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/28/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/28/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/28/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/28/2020

RFNT

REFUSAL PROCESSED BY IB

02/28/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/08/2020

RFRR

REFUSAL PROCESSED BY MPU

02/08/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/17/2020

CNRT

NON-FINAL ACTION WRITTEN

01/16/2020

DOCK

ASSIGNED TO EXAMINER

01/15/2020

MAFR

APPLICATION FILING RECEIPT MAILED

12/10/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/06/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/05/2019

Continuous trademark protection

Get notified about every new filing that threatens TREEFROG THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.